Characterization of molecular clones of porcine endogenous retrovirus-A containing different numbers of U3 repeat boxes in the long terminal repeat region

Journal of Virological Methods

Volumn 181, Issue 1, 2012, Pages 103-108

  Lee, Yong Jin ^a   Park, Sung Han ^a   Bae, Eun Hye ^a   Jung, Yong Tae ^a  

^a Dankook University   (South Korea)

Author keywords

39 bp repeat box; Infectious molecular clone; Porcine endogenous retroviruses; Xenotransplantation

Indexed keywords

NUCLEAR FACTOR Y;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENHANCER REGION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE ENDOGENOUS RETROVIRUS A; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MULTIMERIZATION; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS REPLICATION;

ANIMALS; BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE; ENDOGENOUS RETROVIRUSES; HUMANS; SWINE; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

PORCINE ENDOGENOUS RETROVIRUS; PORCINE ENDOGENOUS RETROVIRUS A; PORCINE ENDOGENOUS RETROVIRUS B;

EID: 84862791689     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.01.023     Document Type: Article

References (33)

1. Bach F.H., Fishman J.A., Daniels N., Proimos J., Anderson B., Carpenter C.B., Forrow L., Robson S.C., Fineberg H.V. Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat. Med. 1998, 4:141-144.
2. Bartosch B., Stefanidis D., Myers R., Weiss R., Patience C., Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J. Virol. 2004, 78:13880-13890.
3. Bartosch B., Weiss R.A., Takeuchi Y. PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J. Gen. Virol. 2002, 83:2231-2240.
4. Boneva R.S., Folks T.M. Xenotransplantation and risks of zoonotic infections. Ann. Med. 2004, 36:504-517.
5. Czauderna F., Fischer N., Boller K., Kurth R., Tonjes R.R. Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J. Virol. 2000, 74:4028-4038.
6. Denner J. Is porcine endogenous retrovirus (PERV) transmission still relevant?. Transplant Proc. 2008, 40:587-589.
7. Denner J., Specke V., Thiesen U., Karlas A., Kurth R. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology 2003, 314:125-133.
8. Fishman J.A. Infection and xenotransplantation. Developing strategies to minimize risk. Ann. N. Y. Acad. Sci. 1998, 862:52-66.
9. Gemeniano M., Mpanju O., Salomon D.R., Eiden M.V., Wilson C.A. The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology 2006, 346:108-117.
10. Golemis E.A., Speck N.A., Hopkins N. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 1990, 64:534-542.
11. Harrison I., Takeuchi Y., Bartosch B., Stoye J.P. Determinants of high titer in recombinant porcine endogenous retroviruses. J. Virol. 2004, 78:13871-13879.
12. Heneine W., Tibell A., Switzer W.M., Sandstrom P., Rosales G.V., Mathews A., Korsgren O., Chapman L.E., Folks T.M., Groth C.G. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998, 352:695-699.
13. Karlas A., Irgang M., Votteler J., Specke V., Ozel M., Kurth R., Denner J. Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. Ann. Transplant. 2010, 15:45-54.
14. Krach U., Fischer N., Czauderna F., Tonjes R. Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells. J. Virol. 2001, 75:5465-5472.
15. Le Tissier P., Stoye J.P., Takeuchi Y., Patience C., Weiss R.A. Two sets of human-tropic pig retrovirus. Nature 1997, 389:681-682.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method 2001, 25:402-408.
17. Maity S.N., Crombrugghe B.de. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem. Sci. 1998, 23:174-178.
18. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999, 239:15-27.
19. Martiney M.J., Rulli K., Beaty R., Levy L.S., Lenz J. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus. J. Virol. 1999, 73:7599-7606.
20. Patience C., Patton G.S., Takeuchi Y., Weiss R.A., McClure M.O., Rydberg L., Breimer M.E. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998, 352:699-701.
21. Patience C., Takeuchi Y., Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 1997, 3:282-286.
22. Pyra H., Böni J., Schüpbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. U. S. A. 1994, 51:1544-1548.
23. Sahs D.H., Sykes M., Robson S.C., Cooper D.K. Xenotransplantatioin. Adv. Immunol. 2001, 79:129-223.
24. Scheef G., Fischer N., Flory E., Schmitt I., Tonjes R.R. Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs. J. Virol. 2002, 76:12553-12563.
25. Scheef G., Fischer N., Krach U., Tonjes R.R. The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells. J. Virol. 2001, 75:6933-6940.
26. Shimotohno K., Golde D.W., Miwa M., Sugimura T., Chen I.S. Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1079-1083.
27. Takeuchi Y., Patience C., Magre S., Weiss R.A., Banerjee P.T., Le Tissier P., Stoye J.P. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 1998, 72:9986-9991.
28. Todaro G.J., Benveniste R.E., Lieber M.M., Sherr C.J. Characterization of a type C virus released from the porcine cell line PK(15). Virology 1974, 58:65-74.
29. Van Beveren C., Rands E., Chattopadhyay S.K., Lowy D.R., Verma I.M. Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site. J. Virol. 1982, 41:542-556.
30. Wilson C.A., Wong S., Muller J., Davidson C.E., Rose T.M., Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 1998, 72:3082-3087.
31. Wilson C.A., Laeeq S., Ritzhaupt A., Colon-Moran W., Yoshimura F.K. Sequence analysis of porcine endogenous retovirus long terminal repeats and identification of transcriptional regulatory regions. J. Virol. 2003, 77:142-149.
32. Whelan J.A., Russel N.B., Whelan M.A. A method for the absolute quantification of cDNA using real time PCR. J. Immunol. Meth. 2003, 278:261-269.
33. Wolgamot G., Miller A.D. Replication of Mus dunni endogenous depends on promoter activation followed by enhancer multimerazation. J. Virol. 1999, 73:9803-9809.